Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Studies

Adipose Triglyceride Lipase

Function, Regulation by Insulin, and Comparison With Adiponutrin

  1. Erin E. Kershaw1,
  2. Jonathan K. Hamm1,
  3. Linda A.W. Verhagen1,
  4. Odile Peroni1,
  5. Masa Katic2 and
  6. Jeffrey S. Flier1
  1. 1Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
  2. 2Joslin Diabetes Center, Boston, Massachusetts
  1. Address correspondence and reprint requests to Erin E. Kershaw, MD, Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. E-mail: ekershaw{at}bidmc.harvard.edu
Diabetes 2006 Jan; 55(1): 148-157. https://doi.org/10.2337/diabetes.55.01.06.db05-0982
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    ATGL and adiponutrin (AN) expression during adipogenesis. ATGL (A) and adiponutrin (B) expression were determined by Q-PCR in 3T3-L1 adipocytes on days 0, 2, 3, 4, 5, and 8 of differentiation (n = 3 per time point). Gene expression was normalized to 18S ribosomal RNA and expressed relative to ATGL expression in day 8 adipocytes.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    ATGL and adiponutrin (AN) expression in various murine tissues. ATGL (A) and adiponutrin (B) expression were determined by Q-PCR in BAT, PGAT, subcutaneous adipose tissue (SCAT), mesenteric adipose tissue (MAT), adrenal gland (ADR), testes (TES), soleus (SOL), tibialis anterior (TA), heart (HRT), lung (LNG), kidney (KID), liver (LIV), and hypothalamus (HYP) of 10-week-old male C57BL/6J mice (n = 6 per group). Gene expression was normalized to 18S ribosomal RNA and expressed relative to ATGL expression in BAT.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Overexpression of ATGL in 3T3-L1 adipocytes. Retroviral-mediated overexpression of ATGL in 3T3-L1 adipocytes was achieved via stable transfection with vector alone (L1-Cont) or vector containing full-length ATGL cDNA (L1-ATGL) (three experiments, n = 3 each). ATGL expression (A), basal (B) and stimulated (C) glycerol release, and basal (D) and stimulated (E) NEFA release were then evaluated at day 4 of differentiation. Gene expression was normalized to 18S ribosomal RNA and expressed relative to ATGL expression in the control group. Glycerol and NEFA release were normalized to total cellular protein and expressed relative to the nonstimulated control group. Iso, isoproterenol. *P < 0.05; **P < 0.01; ****P < 0.0001.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Knockdown of ATGL in 3T3-L1 adipocytes. siRNA-mediated knockdown of ATGL in 3T3-L1 adipocytes was achieved by electroporating 3T3-L1 adipocytes with either control siRNA (Cont) or ATGL-specific siRNA (ATGL) at day 4 of differentiation (three experiments, n = 3 each). ATGL expression (A), basal (B) and stimulated (C) glycerol release, and basal (D) and stimulated (E) NEFA release were then evaluated at day 6 of differentiation. Gene expression was normalized to 18S ribosomal RNA and expressed relative to ATGL expression in the control group. Glycerol and NEFA release were normalized to total cellular protein and expressed relative to the nonstimulated control group. Iso, isoproterenol. ***P < 0.001; ****P < 0.0001.

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Comparison of siRNA-mediated knockdown of ATGL, adiponutrin (AN), and HSL in fully differentiated 3T3-L1 adipocytes. 3T3-L1 adipocytes were electroporated in the presence of control siRNA or siRNAs specific for ATGL, adiponutrin, or HSL, alone or in combination at day 7 of differentiation (n = 3, representative one of two experiments). ATGL (A), adiponutrin (B), and HSL (C) expression were determined by Q-PCR 48 h later. Gene expression was normalized to 18S ribosomal RNA and expressed relative to ATGL expression in the control group. Basal (D) and stimulated (E) glycerol release and basal (F) and stimulated (G) NEFA release were determined at day 9 of differentiation. Glycerol and NEFA release was normalized to total cell protein and expressed relative to the nonstimulated control group. Iso, isoproterenol. *P < 0.05; **P < 0.01; ***P < 0.001; **** P < 0.0001.

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Regulation of ATGL and adiponutrin (AN) expression by nutritional status. ATGL (A) and adiponutrin (B) mRNA expression were determined by Q-PCR in PGAT of 8-week-old male FVB mice that were fed ad libitum (▪), fasted (6, 12, 18, or 24 h) (□), or re-fed (12 or 24 h after a 24-h fast) (□) (n = 10 per group) with the onset of the light cycle (6:00 a.m.) as time 0. Gene expression was normalized to 18S ribosomal RNA and expressed relative to gene expression in ad libitum–fed control mice at time 0.

  • FIG. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Regulation of ATGL and adiponutrin (AN) expression by insulin in 3T3-L1 adipocytes. Dose-response curves for ATGL (A) and adiponutrin (B) expression were generated by incubating fully differentiated 3T3-L1 adipocytes in serum-free DMEM supplemented with insulin at the doses indicated for 12 h (n = 3, representative one of three experiments). Data were normalized to 18S ribosomal RNA and expressed relative to gene expression in control cells incubated without insulin. Time course for ATGL (C) and adiponutrin (D) expression were generated by incubating fully differentiated 3T3-L1 adipocytes in either DMEM containing 10% FBS or serum-free DMEM (serum starved) with and without insulin at 1,000 ng/ml for ATGL or 1 ng/ml for adiponutrin for the time indicated (n = 3, representative one of three experiments). ▪, FBS; •, serum starved; ⧫, FBS plus insulin; ▴, serum starved plus insulin. Data were normalized to 18S and expressed relative to gene expression in the control group at time 0. To convert ng/ml to nmol/l, multiply by 0.174.

  • FIG. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    ATGL and adiponutrin (AN) expression in adipose tissue of STZ-administered mice. ATGL (A) and adiponutrin (B) expression were determined by Q-PCR in PGAT of ad libitum–fed, 10-week-old male mice given vehicle (control), STZ, or STZ followed by insulin replacement for 24 h (STZ + Ins) (n = 8–10 per group). Data were normalized to HPRT and expressed relative to gene expression in the control group. *P < 0.05; ****P < 0.0001.

  • FIG. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    ATGL and adiponutrin (AN) expression in adipose tissue of FIRKO mice. ATGL (A) and adiponutrin (B) expression were determined by Q-PCR in PGAT of 2-year-old, ad libitum–fed, male FIRKO mice (n = 4 per group). Data were normalized to HPRT and expressed relative to gene expression in the control group. *P < 0.05.

PreviousNext
Back to top

In this Issue

January 2006, 55(1)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adipose Triglyceride Lipase
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Adipose Triglyceride Lipase
Erin E. Kershaw, Jonathan K. Hamm, Linda A.W. Verhagen, Odile Peroni, Masa Katic, Jeffrey S. Flier
Diabetes Jan 2006, 55 (1) 148-157; DOI: 10.2337/diabetes.55.01.06.db05-0982

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Adipose Triglyceride Lipase
Erin E. Kershaw, Jonathan K. Hamm, Linda A.W. Verhagen, Odile Peroni, Masa Katic, Jeffrey S. Flier
Diabetes Jan 2006, 55 (1) 148-157; DOI: 10.2337/diabetes.55.01.06.db05-0982
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals
  • Muscular G9a Regulates Muscle-Liver-Fat Axis by Musclin Under Overnutrition in Female Mice
  • Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
Show more Obesity Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.